Related Experiment Videos
Quantitative computed tomography and aerosol morphometry in COPD and alpha1-antitrypsin deficiency
S B Shaker1, N Maltbaek, P Brand
1Dept of Respiratory Medicine, post 58, Gentofte University Hospital, Niels Andersens vej 65, DK-2900 Hellerup, Denmark. saher@dadlnet.dk
The European Respiratory Journal
|January 11, 2005
Summary
Alpha-1 antitrypsin deficiency (AAD) patients show more severe emphysema than smokers with COPD, despite similar lung function. Quantitative CT and airway morphometry revealed differences in emphysema severity between these groups.
Area of Science:
- Pulmonary Medicine
- Radiology
- Respiratory Physiology
Background:
- Emphysema diagnosis relies on quantitative CT parameters like relative emphysema area (RA-910) and 15th percentile density (PD15).
- Aerosol-derived airway morphometry, measuring effective airspace dimensions (EAD) and aerosol bolus dispersion (ABD), offers new noninvasive diagnostic approaches.
Purpose of the Study:
- To compare quantitative CT, EAD, and ABD in smokers with COPD and patients with alpha-1 antitrypsin deficiency (AAD).
- To assess the correlation between these parameters and pulmonary function tests (PFTs) in both groups.
Main Methods:
- Quantitative CT (RA-910, PD15), EAD, and ABD were measured in 20 smokers with COPD and 22 patients with AAD.
- Participants had similar airway obstruction and reduced diffusion capacity.
Main Results:
- Significant correlations were found between RA-910, PD15, and PFTs in both groups.
- EAD correlated with RA-910 and PD15 in the overall study population and significantly in the AAD group.
- ABD showed no significant correlation with PFTs or quantitative CT in either group.
- Emphysema was quantitatively more severe in AAD patients compared to COPD patients.
Conclusions:
- Quantitative CT and airway morphometry indicate more severe emphysema in alpha-1 antitrypsin deficiency patients versus COPD patients.
- Despite similar pulmonary function, AAD is associated with greater emphysema severity.